Antiretroviral therapy switch among Medicare beneficiaries with HIV
Medicare-insured PWH indexed on B/F/TAF had lower risk of treatment switch compared with other ART regimens, both overall and in the subgroup with mental health and/or substance use disorders. These findings may inform targeted strategies for optimal treatment selection for PWH.
Authors
- S. Li
- Uche Mordi
- Seojin Park
- Haifeng Guo
- Woodie Zachry
- Travis Lim
- Phyllis C. Tien
- Mary J. Christoph
Institutions
- University of California, San Francisco (US)
- Metro-Minnesota Community Oncology Research Consortium (US)
- Gilead Sciences (United States) (US)
Publication Details
- Journal
- Journal of Managed Care & Specialty Pharmacy
- Published
- 2026-02-26
- DOI
- https://doi.org/10.18553/jmcp.2026.25275
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00